NRP-1 functions as a receptor on M2 macrophages, and a targeting strategy using AGuIX-KDKPPR nanoparticles could also be extended to other approaches, notably diagnostics, perfecting tumor detection, and monitoring therapeutic responses. Here, NRP1 is linked to neoplasm.